Neonatal Azithromycin Administration and Growth during Infancy: A Randomized Controlled Trial
The American Journal of Tropical Medicine and Hygiene · 2023
DOI: 10.4269/ajtmh.22-0763 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2023. Verfasst von Ali Sie und 15 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche en Santé de Nouna, Burkina Faso. Hauptthemen laut MEDLINE: Azithromycin, Pediatric Obesity. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Observational studies have linked early-life antibiotic exposure to increased risk of obesity in children in high income settings. We evaluated whether neonatal antibiotic exposure led to changes in infant growth at 6 months of age in Burkina Faso. Neonates aged 8 to 27 days of age who weighed at least 2,500 g at the time of enrollment were randomized in a 1:1 fashion to a single oral 20-mg/kg dose of azithromycin or equivalent volume of placebo from April 2019 through December 2020. Weight, length, and mid-upper-arm circumference (MUAC) were measured at baseline and 6 months of age. Growth outcomes, including weight gain in grams per day, length change in millimeters per day, and changes in weight-for-age Z-score (WAZ), weight-for-length Z-score (WLZ), length-for-age Z-score (LAZ), and MUAC were compared among neonates randomized to azithromycin compared with placebo. Among 21,832 neonates enrolled in the trial, median age at enrollment was 11 days, and 50% were female. We found no evidence of a difference in weight gain (mean difference −0.009 g/day, 95% confidence interval [CI]: −0.16 to 0.14, P = 0.90), length change (mean difference 0.003 mm/day, 95% CI: −0.002 to 0.007, P = 0.23), or WAZ (mean difference −0.005 SD, 95% CI: −0.03 to 0.02, P = 0.72), WLZ (mean difference −0.01 SD, 95% CI: −0.05 to 0.02, P = 0.39), LAZ (mean difference 0.01, 95% CI: −0.02 to 0.04, P = 0.47), or MUAC (mean difference 0.01 cm, 95% CI: −0.02 to 0.04, P = 0.49). These results do not suggest that azithromycin has growth-promoting properties in infants when administered during the neonatal period. Trial registration: ClinicalTrials.gov NCT03682653.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre de Recherche en Santé de Nouna, Burkina Faso.
- Francis I Proctor Foundation, University of California, San Francisco.
- Department of Ophthalmology, University of California, San Francisco.
- Department of Epidemiology & Biostatistics, University of California, San Francisco.
- Heidelberg Institute for Global Health, University of Heidelberg, Germany.
- Africa Health Research Institute, Somkhele, South Africa.
Zitieren
APA
Sie, A., Bountogo, M., Zakane, A., Compaoré, G., Ouedraogo, T., Ouattara, M., Lebas, E., Brogdon, J., Nyatigo, F., O'Brien, K. S., Porco, T. C., Bärnighausen, T., Arnold, B. F., Lietman, T. M., Oldenburg, C. E., & NAITRE Study Team (2023). Neonatal Azithromycin Administration and Growth during Infancy: A Randomized Controlled Trial. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.22-0763
Vancouver
Sie A, Bountogo M, Zakane A, Compaoré G, Ouedraogo T, Ouattara M, et al. Neonatal Azithromycin Administration and Growth during Infancy: A Randomized Controlled Trial. The American Journal of Tropical Medicine and Hygiene. 2023. doi:10.4269/ajtmh.22-0763
BibTeX
@article{Sie2023,
author = {Sie, Ali and Bountogo, Mamadou and Zakane, Alphonse and Compaoré, Guillaume and Ouedraogo, Thierry and Ouattara, Mamadou and Lebas, Elodie and Brogdon, Jessica and Nyatigo, Fanice and O'Brien, Kieran S and Porco, Travis C and Bärnighausen, Till and Arnold, Benjamin F and Lietman, Thomas M and Oldenburg, Catherine E and NAITRE Study Team, NAITRE Study Team},
title = {Neonatal Azithromycin Administration and Growth during Infancy: A Randomized Controlled Trial},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2023},
doi = {10.4269/ajtmh.22-0763}
}
EUVIMED